About N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide
N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide (PubChem CID 66991268) has the molecular formula C26H23N7O3
and a molecular weight of 481.52 g/mol. Its IUPAC name is N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide |
| PubChem CID | 66991268 |
| Molecular Formula | C26H23N7O3 |
| Molecular Weight | 481.52 g/mol |
| Exact Mass | 481.19 |
| IUPAC Name | N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide |
| SMILES | Cn1cncc1Cn1cccc(C(=O)NC/C=C/c2ccc3c(c2)NC(=O)C3=Cc2cnc[nH]2)c1=O |
| InChI | InChI=1S/C26H23N7O3/c1-32-16-28-13-19(32)14-33-9-3-5-21(26(33)36)24(34)29-8-2-4-17-6-7-20-22(11-18-12-27-15-30-18)25(35)31-23(20)10-17/h2-7,9-13,15-16H,8,14H2,1H3,(H,27,30)(H,29,34)(H,31,35)/b4-2+,22-11? |
| InChIKey | ZOAGAFQIJXXJMM-KBJURDJBSA-N |
| XLogP | 2.29 |
| TPSA | 126.70 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 481.52 |
| LogP ≤ 5 | 2.29 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Analyze N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide?
The IUPAC name of N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide (CID 66991268) is N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide.
What is the SMILES notation for N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide?
The canonical SMILES for N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide is Cn1cncc1Cn1cccc(C(=O)NC/C=C/c2ccc3c(c2)NC(=O)C3=Cc2cnc[nH]2)c1=O.
What is the InChIKey of N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide?
The InChIKey is ZOAGAFQIJXXJMM-KBJURDJBSA-N. The full InChI is InChI=1S/C26H23N7O3/c1-32-16-28-13-19(32)14-33-9-3-5-21(26(33)36)24(34)29-8-2-4-17-6-7-20-22(11-18-12-27-15-30-18)25(35)31-23(20)10-17/h2-7,9-13,15-16H,8,14H2,1H3,(H,27,30)(H,29,34)(H,31,35)/b4-2+,22-11?.
What are the key properties of N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide?
N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide has a molecular weight of 481.52 g/mol, XLogP of 2.29, 7 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(E)-3-[3-(1H-imidazol-5-ylmethylidene)-2-oxo-1H-indol-6-yl]prop-2-enyl]-1-[(3-methylimidazol-4-yl)methyl]-2-oxopyridine-3-carboxamide is sourced from PubChem (CID 66991268), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).